Literature DB >> 23911752

T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients.

Bettina Balint1, Jürgen Haas, Alexander Schwarz, Sven Jarius, Alexandra Fürwentsches, Kathrin Engelhardt, Cornelia Bussmann, Friedrich Ebinger, Benedikt Fritzsching, Friedemann Paul, Ulrich Seidel, Stefan Vlaho, Peter Huppke, Jutta Gärtner, Brigitte Wildemann.   

Abstract

OBJECTIVE: To assess pediatric patients with multiple sclerosis (MS) for early signs of homeostatic and functional abnormalities in conventional (Tcon) and regulatory T cells (Treg).
METHODS: We studied the composition of the peripheral T-cell compartment and Treg function in a cross-sectional study with 30 pediatric MS (pMS) patients by multicolor flow cytometry and proliferation assays. Data were compared to those obtained from adult patients (n = 26) and age-matched control donors (n = 67).
RESULTS: Proportions of naive T cells were 10%-20% higher in children than in adults, reflecting the age-related decline. pMS patients, however, had clearly lower numbers of naive T cells, among them recent thymic emigrants (RTE), whereas percentages of memory T cells were increased. In the Treg compartment, reduced RTE numbers coincided with markedly dampened suppressive capacities of total Treg. These homeostatic changes in circulating T cells precisely paralleled the pattern seen in adult MS. As in adults, treatment with immunomodulatory drugs attenuated these alterations.
CONCLUSION: The homeostatic changes detected in the T-cell compartment in pMS are similar to those in adult-onset disease. With ratios between naive and memory T-cell subsets matching those of 20- to 30-years-older controls, signs of early thymic involution are already found in pMS, suggesting that an intrinsic compromise in thymic-dependent T-cell neogenesis might contribute to MS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23911752     DOI: 10.1212/WNL.0b013e3182a2ce0e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

Review 1.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

Review 2.  Novel therapies for memory cells in autoimmune diseases.

Authors:  P Bhargava; P A Calabresi
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

3.  Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.

Authors:  Imran H Mohiuddin; Vinodh Pillai; Ethan J Baughman; Benjamin M Greenberg; Elliot M Frohman; Michael P Crawford; Sushmita Sinha; Nitin J Karandikar
Journal:  Clin Immunol       Date:  2016-05-03       Impact factor: 3.969

Review 4.  TGF-β regulation of encephalitogenic and regulatory T cells in multiple sclerosis.

Authors:  Priscilla W Lee; Mary E Severin; Amy E Lovett-Racke
Journal:  Eur J Immunol       Date:  2017-02-10       Impact factor: 5.532

5.  Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.

Authors:  Francisco J Quintana; Bonny Patel; Ada Yeste; Mukanthu Nyirenda; Jessica Kenison; Roya Rahbari; Dumitru Fetco; Mohammad Hussain; Julia O'Mahony; Sandra Magalhaes; Melissa McGowan; Trina Johnson; Sathy Rajasekharan; Sridar Narayanan; Douglas L Arnold; Howard L Weiner; Brenda Banwell; Amit Bar-Or
Journal:  Neurology       Date:  2014-11-07       Impact factor: 9.910

6.  MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.

Authors:  Mary E Severin; Priscilla W Lee; Yue Liu; Amanda J Selhorst; Matthew G Gormley; Wei Pei; Yuhong Yang; Mireia Guerau-de-Arellano; Michael K Racke; Amy E Lovett-Racke
Journal:  Brain       Date:  2016-04-28       Impact factor: 13.501

Review 7.  Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis.

Authors:  Marisa McGinley; Ian T Rossman
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 8.  Pediatric Multiple Sclerosis: an Update.

Authors:  Scott Otallah; Brenda Banwell
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-18       Impact factor: 5.081

9.  Multiple sclerosis patients have reduced resting and increased activated CD4+CD25+FOXP3+T regulatory cells.

Authors:  Nirupama D Verma; Andrew D Lam; Christopher Chiu; Giang T Tran; Bruce M Hall; Suzanne J Hodgkinson
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

10.  T cell transgressions: Tales of T cell form and function in diverse disease states.

Authors:  Kevin M Harris; Madison A Clements; Andrew J Kwilasz; Linda R Watkins
Journal:  Int Rev Immunol       Date:  2021-06-21       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.